Dr. Lu-Yao's research focuses on cancer epidemiology, translational outcomes research, and geriatric oncology. She has led several large clinical epidemiological studies, providing benchmark data that continue to influence prostate cancer treatment guidelines. Her work aims to improve the quality of cancer care delivery by conducting transdisciplinary integrated population science research and developing tools for informed shared decision-making, promoting precision medicine, and reducing health disparities. In particular, Dr. Lu-Yao focuses on reducing health disparities and geriatric oncology. Her research aims to improve the outcomes of older patients with cancer and multiple comorbidities, who are often excluded from clinical trials.
Grace Lu-Yao, PhD, MPH
Research Director, Neu Center
Professor
Contact Information
Benjamin Franklin Building
834 Chestnut Street
Suite 311
Philadelphia, PA 19107
Research Director, Neu Center
Professor
research & Clinical interest
Education
Medical School
Taipei Medical College
Residency
State University of New York at Stony Brooke, NY - 1986
Post-Graduate Education
PhD, Edipemiology, Yale University - 1990
Masters in Public Health, Yale University - 1988
Most Recent Peer-Reviewed Publications
- Assessing the Feasibility of a Self-Management Intervention for Individuals With Advanced Prostate Cancer and Comorbid Type II Diabetes Mellitus
- Risk of fracture following androgen receptor pathway inhibitors in men with advanced prostate cancer
- Prevalence of adverse events following T-cell redirecting therapies in patients with metastatic castration-resistant prostate cancer: a pooled analysis
- A Prospective Validation of the Decipher Genomic Classifier in Men With Early Localized Prostate Cancer: The VANDAAM Study
- Unveiling Factors Associated With Older Adult Accrual to Cancer Clinical Trials: Lessons From the ECOG-ACRIN Experience